Acadian Asset Management LLC Kura Oncology, Inc. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$7.95 - $18.81 $61,159 - $144,705	-7,693 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$6.45 - $14.04 $38,732 - $84,310	6,005 Added 355.75%	7,693 $77,000
Q4 2019 Feb 06, 2020	BUY	$12.97 - $15.94 $21,893 - $26,906	1,688 New	1,688 $23,000
Q3 2019 Nov 07, 2019	SELL	$14.75 - $20.87 $44,486 - $62,943	-3,016 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$14.71 - $19.79 $44,365 - $59,686	3,016 New	3,016 $59,000

Q2 2018 Jul 24, 2018	SELL	$14.8 - $18.8 $128,774 - $163,578	-8,701 Closed	0 $0
Q1 2018 Apr 12, 2018	BUY	$14.5 - $23.4 $126,164 - $203,603	8,701 New	8,701 $163,000

172

80.8M

914K

120K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.41B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.